Please provide your email address to receive an email when new articles are posted on . Edward V. Loftus Jr. Though I see some interesting mirrors between pediatric and adult gastroenterology in the ...

Constipation in children can be caused by a range of problems including the use of certain medications, poor health or a lack of proper nutrition. A teenager who freezes when confronted with using the ...

Credit: Getty Images. The application was supported by data from a phase 3 trial that included 330 patients 6 to 17 years of age with functional constipation. The Food and Drug Administration (FDA) ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio There is currently not enough evidence to ...

Credit: Shutterstock. Linzess is a guanylate cyclase-C agonist. The Food and Drug Administration (FDA) has approved Linzess ® (linaclotide) for the treatment of functional constipation (FC) in ...

A newly approved option for pediatric patients with functional constipation significantly increased the frequency of bowel movements and improved other burdensome symptoms as well, according to a ...

I received a question from one of our twitter followers about her daughter who was recently found to be constipated. She wanted some information on treating constipation. Do you know how common ...

There are no known causes and usually multiple factors leading to the common condition that makes stools hard and difficult to pass, according to the FDA. Linzess was approved in 2012 for adult ...

The US Food and Drug Administration (FDA) has approved Linzess (linaclotide) as the first treatment for children living with irritable bowel syndrome with constipation (IBS-C), as the former ...

The outlook assumes net sales for Linzess will be between $1.125 billion and $1.175 billion in FY2026. ・U.S. FDA had approved ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. AbbVie, in collaboration with Ironwood ...